From 21042c9ac9891d83cacd9f0b1c23c00d2198230f Mon Sep 17 00:00:00 2001 From: clarkchill846 Date: Mon, 28 Sep 2026 23:00:32 +0800 Subject: [PATCH] Add Blood Glucose Monitoring --- Blood-Glucose-Monitoring.md | 9 +++++++++ 1 file changed, 9 insertions(+) create mode 100644 Blood-Glucose-Monitoring.md diff --git a/Blood-Glucose-Monitoring.md b/Blood-Glucose-Monitoring.md new file mode 100644 index 0000000..235f133 --- /dev/null +++ b/Blood-Glucose-Monitoring.md @@ -0,0 +1,9 @@ +
Continuous glucose monitors measure the concentration of glucose in a sample of interstitial fluid. Patients, therefore, require traditional fingerstick measurements for calibration (typically twice per day) and are often advised to use fingerstick measurements to confirm hypo- or hyperglycemia before taking corrective action. The lag time mentioned above has been reported to be about 5 minutes. Anecdotally, some users of the various systems report lag times of up to 10-15 minutes. This lag time is insignificant when blood sugar levels are relatively consistent. However, blood sugar levels, when changing rapidly, may read in the normal range on a CGM system while in reality the patient is already experiencing symptoms of an out-of-range [GlycoMode blood sugar support](https://azbongda.com/index.php/Th%C3%A0nh_vi%C3%AAn:JosephineHillary) glucose value and may require treatment. Patients using CGM are therefore advised to consider both the absolute value of the blood glucose level given by the system as well as any trend in the blood glucose levels.
+ +
For example, a patient using CGM with a blood glucose of 100 mg/dl on their CGM system might take no action if their blood glucose has been consistent for several readings, while a patient with the same blood glucose level but whose blood glucose has been dropping steeply in a short period of time might be advised to perform a fingerstick test to check for hypoglycemia. Continuous monitoring allows examination of how the blood glucose level reacts to insulin, exercise, food, and other factors. The additional data can be useful for setting correct insulin dosing ratios for food intake and correction of hyperglycemia. Monitoring during periods when [GlycoMode blood sugar supplement](https://pilates.wiki/index.php/Glyco_Balance_Reviews:_A_Comprehensive_Analysis) glucose levels are not typically checked (e.g. overnight) can help to identify problems in insulin dosing (such as basal levels for insulin pump users or long-acting insulin levels for patients taking injections). Monitors may also be equipped with alarms to alert patients of hyperglycemia or hypoglycemia so that a patient can take corrective action(s) (after fingerstick testing, if necessary) even in cases where they do not feel symptoms of either condition.
+ +
While the technology has its limitations, studies have demonstrated that patients with continuous sensors experience a smaller number of hyperglycemic and hypoglycemic events, a reduction in their glycated hemoglobin levels and a decrease in glycemic variability. Compared to intermittent testing, it is likely to help reduce hypertensive complications during pregnancy. In addition, investigations on the use of test strips have shown that the required self-injury acts as a psychological barrier restraining the patients from sufficient glucose control. The excessive glucose levels partially resulting from it, and the resulting [secondary diseases](https://www.search.com/web?q=secondary%20diseases) from those levels can be decreased through the use of continuous monitoring. POC blood gas analysers, as this is more reliable and is not affected by the variability of different confusion factors. Determining glycaemia in capillary blood using glucometry may be suitable in stable patients or when close monitoring of glycaemia is not required. Continuous [GlycoMode blood sugar formula](http://leadmall.kr/bbs/board.php?bo_table=qa&wr_id=8500) glucose monitoring is not automatically covered by health insurance in the United States in the same way that most other diabetic supplies are covered (e.g. standard glucose testing supplies, insulin, and insulin pumps). However, an increasing number of insurance companies do cover continuous glucose monitoring supplies (both the receiver and disposable sensors) on a case-by-case basis if the patient and doctor show a specific need. The lack of insurance coverage is exacerbated by the fact that disposable sensors must be frequently replaced. Some sensors have been U.S. Food and Drug Administration (FDA) approved for 7- and 3-day use, (although some patients wear sensors for longer than the recommended period) and the receiving meters likewise have finite lifetimes (less than 2 years and as little as 6 months).
+ +
A British firm, ICI, has developed strains of bacteria capable of producing plastics with a range of properties, including variant degrees of elasticity. The plastic is one hundred percent biodegradable and can be used in much the same way as petrochemical-based plastic resins. In 1993, Dr. Chris Sommerville, the director of plant biology at the Carnegie Institution of Washington, inserted a plastic-making gene into a mustard plant. The gene transforms the plant into a plastics factory. Researchers are experimenting with even more exotic ways of creating new fibers and packaging materials. The United States Army is inserting genes into bacteria that are similar to the genes used by orb-weaving spiders to make silk. The spiders' silk is among the strongest fibers known to exist. Scientists hope to grow the silk-gene-producing bacteria in industrial vats and harvest it for use in products ranging from aircraft parts to bulletproof vests. Biotechnology is also being looked to as a key tool in environmental cleanup.
+ +
Bioremediation is the use of living organisms--primarily microorganisms--to remove or render harmless dangerous pollutants and hazardous waste. A new generation of genetically engineered organisms is being developed to convert toxic materials into benign substances. Researchers are using genetically engineered fungi, bacteria, and algae as "biosorption" systems to capture polluting metals and radionuclides including mercury, copper, cadmium, uranium, and cobalt. One biotech company, The Institute for Genomic Research, has successfully sequenced a microbe that can absorb large amounts of radioactivity. Company scientists hope to use the genes that code for the "uranium-gobbling pathway" to fashion new biological means of cleaning up radioactive dump sites. With more than 200 million tons of hazardous materials being generated annually in the U.S. 1.7 trillion, industry analysts see bioremediation as one of the growth industries in the Biotech Century. Forestry companies have also turned to the new science in hopes of finding genes that can be inserted into trees to make them faster growing, resistant to disease, and better able to withstand heat, cold, and drought.
\ No newline at end of file